when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 2
fostroxacitabine bralpamide hydrochloride
fostroxacitabine bralpamide hydrochloride
Hepatocellular Carcinoma Medivir AB
pre_registration
fovinaciclib
fovinaciclib [INN]
Breast Cancer Shanghai Fosun Pharmaceutical (Group) Co Ltd
Phase 2
fulzerasib
fulzerasib [INN]
Metastatic Colorectal Cancer GenFleet Therapeutics (Shanghai) Inc
Phase 3

page 47 of 62

furmonertinib mesylate

furmonertinib mesylate

Non-Small Cell Lung Cancer

$AVBP ArriVent BioPharma, Inc.

Phase 3

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$SLS SELLAS Life Sciences Group, Inc.

Phase 2

garetatug rezetecan

garetatug rezetecan [INN]

Gastric Cancer Jiangsu Hengrui Pharmaceuticals Co Ltd

pre_registration

Human Epidermal Growth Factor Receptor 2 Negative Breast…$CELC Celcuity Inc.

Phase 2

Nasopharyngeal Cancer$GOVX GeoVax Labs, Inc.

Marketed

Non-Small Cell Lung Cancer Actavis Laboratories NY Inc (Inactive)

Phase 1

Avgemsi (gemcitabine)

Pancreatic Cancer Continuity Biosciences LLC

Phase 2

gemogenovatucel-T

Vigil (gemogenovatucel-T)

Endometrial Cancer Gradalis Inc

Marketed

gemtuzumab ozogamicin

Mylotarg (gemtuzumab ozogamicin)

Refractory Acute Myeloid Leukemia$PFE PFIZER INC

Preclinical

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Changchun High-Tech Industry Group Co Ltd

Marketed

gilteritinib fumarate

Xospata (gilteritinib fumarate)

Refractory Acute Myeloid Leukemia Astellas Pharma US Inc

Phase 1

gintemetostat tartrate

gintemetostat tartrate

Refractory Multiple Myeloma K36 Therapeutics Inc

pre_registration

Human Epidermal Growth Factor Receptor 2 Negative Breast… Genentech Inc

Marketed

givinostat hydrochloride

Duvyzat (givinostat hydrochloride)

Polycythemia Vera Italfarmaco SpA

Marketed

Daurismo (glasdegib)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$PFE PFIZER INC

Phase 2

glecirasib [INN]

Non-Small Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd

Phase 3

glufosfamide [INN]

Metastatic Adenocarcinoma of The Pancreas Eleison Pharmaceuticals Inc

Phase 2

Small-Cell Lung Cancer$MRK Merck & Co., Inc.

Phase 2

Peripheral T-Cell Lymphomas (PTCL) Dizal Pharmaceutical Co Ltd

Phase 3

Non-Small Cell Lung Cancer OncoC4 Inc

Phase 2

guadecitabine sodium

guadecitabine sodium

Fallopian Tube Cancer Astex Pharmaceuticals Inc

Preclinical

guanidine hydrochloride

Unspecified Cancer Kong's Pharmaceutical Co

Phase 2

gumarontinib [INN]

Non-Small Cell Lung Cancer Shanghai Haihe Biopharma Co Ltd

Phase 2

Human Epidermal Growth Factor Receptor 2 Negative Breast… Minerva Biotechnologies Corp

Phase 2

Human Epidermal Growth Factor Receptor 2 Negative Breast… Minerva Biotechnologies Corp

Marketed

human papillomavirus (virus like particle, 9-valent) vaccine

Cervical Intraepithelial Neoplasia (CIN)$MRK Merck & Co., Inc.

Marketed

hydrogen peroxide

hydrogen peroxide [USP]

Cervical Cancer Kortuc Japan LLC